• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

转录组和开放染色质分析揭示了长 QT 综合征 7 型心肌细胞发育的过程和关键致病靶蛋白。

Transcriptome and open chromatin analysis reveals the process of myocardial cell development and key pathogenic target proteins in Long QT syndrome type 7.

机构信息

Department of Clinical Nutrition & Health Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.

出版信息

J Transl Med. 2024 Mar 25;22(1):307. doi: 10.1186/s12967-024-05125-7.

DOI:10.1186/s12967-024-05125-7
PMID:38528561
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10964537/
Abstract

OBJECTIVE

Long QT syndrome type 7 (Andersen-Tawil syndrome, ATS), which is caused by KCNJ2 gene mutation, often leads to ventricular arrhythmia, periodic paralysis and skeletal malformations. The development, differentiation and electrophysiological maturation of cardiomyocytes (CMs) changes promote the pathophysiology of Long QT syndrome type 7(LQT7). We aimed to specifically reproduce the ATS disease phenotype and study the pathogenic mechanism.

METHODS AND RESULTS

We established a cardiac cell model derived from human induced pluripotent stem cells (hiPSCs) to the phenotypes and electrophysiological function, and the establishment of a human myocardial cell model that specifically reproduces the symptoms of ATS provides a reliable platform for exploring the mechanism of this disease or potential drugs. The spontaneous pulsation rate of myocardial cells in the mutation group was significantly lower than that in the repair CRISPR group, the action potential duration was prolonged, and the Kir2.1 current of the inward rectifier potassium ion channel was decreased, which is consistent with the clinical symptoms of ATS patients. Only ZNF528, a chromatin-accessible TF related to pathogenicity, was continuously regulated beginning from the cardiac mesodermal precursor cell stage (day 4), and continued to be expressed at low levels, which was identified by WGCNA method and verified with ATAC-seq data in the mutation group. Subsequently, it indicated that seven pathways were downregulated (all p < 0.05) by used single sample Gene Set Enrichment Analysis to evaluate the overall regulation of potassium-related pathways enriched in the transcriptome and proteome of late mature CMs. Among them, the three pathways (GO: 0008076, GO: 1990573 and GO: 0030007) containing the mutated gene KCNJ2 is involved that are related to the whole process by which a potassium ion enters the cell via the inward rectifier potassium channel to exert its effect were inhibited. The other four pathways are related to regulation of the potassium transmembrane pathway and sodium:potassium exchange ATPase (p < 0.05). ZNF528 small interfering (si)-RNA was applied to hiPSC-derived cardiomyocytes for CRISPR group to explore changes in potassium ion currents and growth and development related target protein levels that affect disease phenotype. Three consistently downregulated proteins (KCNJ2, CTTN and ATP1B1) associated with pathogenicity were verificated through correlation and intersection analysis.

CONCLUSION

This study uncovers TFs and target proteins related to electrophysiology and developmental pathogenicity in ATS myocardial cells, obtaining novel targets for potential therapeutic candidate development that does not rely on gene editing.

摘要

目的

长 QT 综合征 7 型(Andersen-Tawil 综合征,ATS)由 KCNJ2 基因突变引起,常导致室性心律失常、周期性瘫痪和骨骼畸形。心肌细胞(CMs)的发育、分化和电生理成熟变化促进了长 QT 综合征 7 型(LQT7)的病理生理学。我们旨在专门复制 ATS 疾病表型并研究致病机制。

方法和结果

我们建立了一种源自人类诱导多能干细胞(hiPSC)的心脏细胞模型,以表型和电生理功能为特征,并建立了一种专门复制 ATS 症状的人类心肌细胞模型,为探索该疾病的机制或潜在药物提供了可靠的平台。突变组心肌细胞的自发搏动率明显低于修复 CRISPR 组,动作电位持续时间延长,内向整流钾离子通道的 Kir2.1 电流减少,与 ATS 患者的临床症状一致。只有与致病性相关的染色质可及性 TF(转录因子)ZNF528 从心脏中胚层前体细胞阶段(第 4 天)开始持续被调控,并在突变组中通过 ATAC-seq 数据进行验证,表达水平持续较低。随后,通过单样本基因集富集分析(GSVA)评估富含成熟晚期 CMs 转录组和蛋白质组的钾相关途径的整体调控,发现七个途径被下调(均 p<0.05)。其中,涉及突变基因 KCNJ2 的三个途径(GO:0008076、GO:1990573 和 GO:0030007)被抑制,这些途径涉及钾离子通过内向整流钾通道进入细胞以发挥作用的整个过程。其他四个途径与钾跨膜途径和钠:钾交换 ATP 酶(p<0.05)的调节有关。为了探索影响疾病表型的钾离子电流和与生长发育相关的靶蛋白水平的变化,我们将 ZNF528 小干扰(si)-RNA 应用于 hiPSC 衍生的心肌细胞的 CRISPR 组。通过相关性和交集分析验证了与致病性相关的三个一致下调的蛋白质(KCNJ2、CTTN 和 ATP1B1)。

结论

本研究揭示了 ATS 心肌细胞中与电生理和发育致病性相关的 TFs 和靶蛋白,为不依赖于基因编辑的潜在治疗候选物开发提供了新的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/30977d6880a6/12967_2024_5125_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/6c873c6dbbbf/12967_2024_5125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/d365765d5dbb/12967_2024_5125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/88e5bad8ea84/12967_2024_5125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/2bb5b7fb1d32/12967_2024_5125_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/7c99bed7492d/12967_2024_5125_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/d6cc3fb41e81/12967_2024_5125_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/03b2347c23c0/12967_2024_5125_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/30977d6880a6/12967_2024_5125_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/6c873c6dbbbf/12967_2024_5125_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/d365765d5dbb/12967_2024_5125_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/88e5bad8ea84/12967_2024_5125_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/2bb5b7fb1d32/12967_2024_5125_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/7c99bed7492d/12967_2024_5125_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/d6cc3fb41e81/12967_2024_5125_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/03b2347c23c0/12967_2024_5125_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/10ac/10964537/30977d6880a6/12967_2024_5125_Fig8_HTML.jpg

相似文献

1
Transcriptome and open chromatin analysis reveals the process of myocardial cell development and key pathogenic target proteins in Long QT syndrome type 7.转录组和开放染色质分析揭示了长 QT 综合征 7 型心肌细胞发育的过程和关键致病靶蛋白。
J Transl Med. 2024 Mar 25;22(1):307. doi: 10.1186/s12967-024-05125-7.
2
Andersen-Tawil syndrome: clinical and molecular aspects.Andersen-Tawil 综合征:临床与分子方面。
Int J Cardiol. 2013 Dec 5;170(1):1-16. doi: 10.1016/j.ijcard.2013.10.010.
3
Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study.IK1降低情况下与安德森-塔维尔综合征相关的室性心律失常的电生理机制:一项模拟研究
Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2597-605. doi: 10.1152/ajpheart.00393.2006. Epub 2006 Jul 28.
4
Identification and functional characterisation of a novel KCNJ2 mutation, Val302del, causing Andersen-Tawil syndrome.一种导致安德森-塔维尔综合征的新型KCNJ2突变Val302del的鉴定与功能表征。
Can J Physiol Pharmacol. 2015 Jul;93(7):569-75. doi: 10.1139/cjpp-2014-0527. Epub 2015 Apr 17.
5
Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.与安德森-塔维尔综合征相关的KCNJ2基因突变的功能和临床特征
J Med Genet. 2006 Aug;43(8):653-9. doi: 10.1136/jmg.2006.040816. Epub 2006 Mar 29.
6
Andersen-Tawil Syndrome安德森-塔维尔综合征
7
Molecular stratification of arrhythmogenic mechanisms in the Andersen Tawil syndrome. Andersen-Tawil 综合征的心律失常机制的分子分层。
Cardiovasc Res. 2023 May 2;119(4):919-932. doi: 10.1093/cvr/cvac118.
8
[Andersen-Tawil syndrome: a review of its clinical and genetic diagnosis with emphasis on cardiac manifestations].[安德森-陶威尔综合征:临床与基因诊断综述,重点关注心脏表现]
Arch Cardiol Mex. 2014 Oct-Dec;84(4):278-85. doi: 10.1016/j.acmx.2013.12.007. Epub 2014 Sep 27.
9
Kir2.1 Interactome Mapping Uncovers PKP4 as a Modulator of the Kir2.1-Regulated Inward Rectifier Potassium Currents.Kir2.1 相互作用组图谱揭示 PKP4 作为 Kir2.1 调节内向整流钾电流的调节剂。
Mol Cell Proteomics. 2020 Sep;19(9):1436-1449. doi: 10.1074/mcp.RA120.002071. Epub 2020 Jun 15.
10
Kir 2.1 channelopathies: the Andersen-Tawil syndrome.Kir2.1 通道病: Andersen-Tawil 综合征。
Pflugers Arch. 2010 Jul;460(2):289-94. doi: 10.1007/s00424-010-0820-6. Epub 2010 Mar 21.

引用本文的文献

1
Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application.染色质可及性:生物学功能、分子机制及治疗应用
Signal Transduct Target Ther. 2024 Dec 4;9(1):340. doi: 10.1038/s41392-024-02030-9.

本文引用的文献

1
Temporal analysis of enhancers during mouse cerebellar development reveals dynamic and novel regulatory functions.在小鼠小脑发育过程中对增强子进行的时程分析揭示了动态的和新颖的调控功能。
Elife. 2022 Aug 9;11:e74207. doi: 10.7554/eLife.74207.
2
Spatial profiling of early primate gastrulation in utero.子宫内早期灵长类动物原肠胚形成的空间分析。
Nature. 2022 Sep;609(7925):136-143. doi: 10.1038/s41586-022-04953-1. Epub 2022 Jun 16.
3
Grainyhead-like (Grhl) Target Genes in Development and Cancer.粒头样 (Grhl) 靶基因在发育和癌症中的作用。
Int J Mol Sci. 2022 Mar 1;23(5):2735. doi: 10.3390/ijms23052735.
4
DLX5/6 GABAergic Expression Affects Social Vocalization: Implications for Human Evolution.DLX5/6 表达的 GABA 能影响社交发声:对人类进化的启示。
Mol Biol Evol. 2021 Oct 27;38(11):4748-4764. doi: 10.1093/molbev/msab181.
5
Modeling Human TBX5 Haploinsufficiency Predicts Regulatory Networks for Congenital Heart Disease.建模人类 TBX5 单倍体不足预测先天性心脏病的调控网络。
Dev Cell. 2021 Feb 8;56(3):292-309.e9. doi: 10.1016/j.devcel.2020.11.020. Epub 2020 Dec 14.
6
ATAC-Seq Reveals an Enhancer That Regulates Sinoatrial Node Development and Function.ATAC-Seq 揭示了一个调节窦房结发育和功能的增强子。
Circ Res. 2020 Dec 4;127(12):1502-1518. doi: 10.1161/CIRCRESAHA.120.317145. Epub 2020 Oct 12.
7
Intracellular calcium current disorder and disease phenotype in mutant iPSC-based cardiomyocytes in arrhythmogenic right ventricular cardiomyopathy.致心律失常性右心室心肌病中突变 iPSC 基心肌细胞的细胞内钙电流紊乱和疾病表型。
Theranostics. 2020 Sep 14;10(24):11215-11229. doi: 10.7150/thno.45172. eCollection 2020.
8
Genome-Wide Analysis Identifies an Essential Human TBX3 Pacemaker Enhancer.全基因组分析鉴定出人类 TBX3 起搏器的必需增强子。
Circ Res. 2020 Dec 4;127(12):1522-1535. doi: 10.1161/CIRCRESAHA.120.317054. Epub 2020 Oct 12.
9
Generation and trapping of a mesoderm biased state of human pluripotency.生成并捕获偏向中胚层的人类多能性状态。
Nat Commun. 2020 Oct 5;11(1):4989. doi: 10.1038/s41467-020-18727-8.
10
Preclinical evidence for the therapeutic value of TBX5 normalization in arrhythmia control.TBX5 正常化在心律失常控制中的治疗价值的临床前证据。
Cardiovasc Res. 2021 Jul 7;117(8):1908-1922. doi: 10.1093/cvr/cvaa239.